Brief: Ondine Biomedical Recruits First Patient For US Phase 3 Trial
30/12/2024 07:04
Dec 30 (Reuters) - Ondine Biomedical Inc OBI.L :
* ONDINE BIOMEDICAL - ONDINE RECRUITS FIRST PATIENT FOR US
PHASE
3 TRIAL
* ONDINE BIOMEDICAL INC - FINAL PATIENT EXPECTED TO ENROLL
IN
MID-2025
Source text: ID:nRSd5692Ra
Further company coverage: OBI.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ondine Biomedical
See all newsBrief: Ondine Lantern Phase 3 Database Lock Expected Within A Week; Top-Line Results In 1-2 Weeks
Ondine Biomedical - Leeds Drops SSIs by 78.5% in Complex Brain Surgery
Brief: Ondine Biomedical Expects 2026 To Be A Defining Year For Company
Ondine Biomedical - Notice of AGM
Ondine Biomedical - 2025 Full Year Results and Annual Report